![AbbVie inks yet another Humira biosim deal—this time with Novartis—as EU launches near | Fierce Pharma AbbVie inks yet another Humira biosim deal—this time with Novartis—as EU launches near | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1539348675/large.img_.png?VersionId=vQteJHcme_xpl5D71KYl6FypWPAVbX6s)
AbbVie inks yet another Humira biosim deal—this time with Novartis—as EU launches near | Fierce Pharma
![HUMIRA (Adalimumab Drug) Market Size, Share, Report, Growth, Analysis, Key Players, Price, Trends and Forecast Period 2023-2031 - Tech Guest Posts Tech Guest Posts | SIIT | IT Training & Technical Certification Courses Online HUMIRA (Adalimumab Drug) Market Size, Share, Report, Growth, Analysis, Key Players, Price, Trends and Forecast Period 2023-2031 - Tech Guest Posts Tech Guest Posts | SIIT | IT Training & Technical Certification Courses Online](https://siit.co/guestposts/wp-content/uploads/2023/03/HUMIRA-Adalimumab-Drug-Market.png)
HUMIRA (Adalimumab Drug) Market Size, Share, Report, Growth, Analysis, Key Players, Price, Trends and Forecast Period 2023-2031 - Tech Guest Posts Tech Guest Posts | SIIT | IT Training & Technical Certification Courses Online
![AbbVie sustains aggressive Humira push, GSK amps up on Breo to top March TV spenders | Fierce Pharma AbbVie sustains aggressive Humira push, GSK amps up on Breo to top March TV spenders | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/2016-04/humiramarch.png?VersionId=LIM6j771a6HngsqbmDRj2fJauyxsnmrm)
AbbVie sustains aggressive Humira push, GSK amps up on Breo to top March TV spenders | Fierce Pharma
![Physicochemical and Functional Characterization of HS016, a Biosimilar of Adalimumab (Humira) - Journal of Pharmaceutical Sciences Physicochemical and Functional Characterization of HS016, a Biosimilar of Adalimumab (Humira) - Journal of Pharmaceutical Sciences](https://jpharmsci.org/cms/asset/09ecc097-f9c8-4727-8c24-d84a7a950173/gr1.jpg)